Are Peptides Legal in West Virginia? (2026)

By the Peptide Bureau Research Team Regulation Reviewed by the Peptide Bureau Research Team on 28 September 2026

Not legal advice. This page summarises public statutes, board statements and enforcement records for West Virginia as of 28 September 2026, for general information. It is not a legal opinion. Laws change; check the linked sources or a licensed West Virginia attorney before relying on anything here. Compounds are discussed in a research context only.

Short answer. There is no West Virginia statute that bans buying or possessing research peptides as a category. Federal law does the regulating: selling an unapproved peptide for human use is a federal violation by the seller, and human growth hormone has its own federal statute. West Virginia does go further on at least one compound: Human growth hormone, Schedule III, Human chorionic gonadotropin (hCG), Schedule III (details below). West Virginia also lists human growth hormone in its own controlled-substance law, on top of the federal rule. The West Virginia Board of Pharmacy has taken a position on compounded semaglutide or tirzepatide, which matters if you are looking at a clinic or telehealth prescription rather than a research vial. Verified against the sources listed at the bottom on 28 September 2026. Not legal advice.

West Virginia at a glance

State controlled-substances law: West Virginia Uniform Controlled Substances Act, W. Va. Code ch. 60A (§ 60A-1-101 et seq.) (code.wvlegislature.gov)
Human growth hormone under state law: Listed as a controlled substance in state law (W. Va. Code § 60A-2-208(g)) (code.wvlegislature.gov)
Research peptides scheduled by the state: Human growth hormone, Schedule III (W. Va. Code § 60A-2-208(g)) (code.wvlegislature.gov), Human chorionic gonadotropin (hCG), Schedule III (W. Va. Code § 60A-2-208(i), except approved veterinary use) (code.wvlegislature.gov)
Board of Pharmacy on compounded GLP-1s: The Board of Pharmacy's Statement Concerning Semaglutide Compounding (April 2023, updated 1 May 2023) says compounding semaglutide is generally prohibited as a copy of a commercially available drug and allowed only while the drug is on the FDA shortage list or with a documented patient-specific change; that no salt form of semaglutide (sodium or acetate) may be used because only the base is a component of an approved drug and semaglutide is not on the 503A bulks list; that the active ingredient must be pharmaceutical grade from an FDA-registered establishment; and that research-use-only products may not be used for compounding in any circumstance (2023-05-01) (wvbop.com)
Medical board on peptide prescribing: No statement located
GLP-1 by telehealth: Yes, by real-time audio-video or audio-only telemedicine. W. Va. Code § 30-3-13a bars establishing the physician-patient relationship through email, internet questionnaires or text, says a prescription based solely on an online questionnaire is not an acceptable standard of care, and requires an in-person visit with a practitioner within twelve months of the first telemedicine service for the service to continue. (code.wvlegislature.gov)
State-level enforcement, 2023 to 2026: 1 action found
Last verified: 28 September 2026, confidence high

The federal rules that apply in West Virginia, as everywhere

Federal law is the same in every state, and it is where almost all of the legal weight sits. Under the Federal Food, Drug, and Cosmetic Act a product intended to treat a condition or change how the body works is a drug, and an unapproved new drug cannot be introduced into interstate commerce. That rule binds the seller, not the buyer. The FDA's 2026 warning letters to research-peptide vendors say the same thing eleven times over: a "research use only" label does not help when the website, the bundled bacteriostatic water or a dosing calculator shows the product is meant for human use. The Bureau's enforcement tracker lists every letter, case and lawsuit with its source.

Three federal points matter for a reader in West Virginia:

Human growth hormone is the exception. 21 U.S.C. § 333(e) makes it a federal offence to distribute or possess somatropin for any use not approved by the Secretary of HHS. That statute covers HGH itself, not the secretagogues (sermorelin, ipamorelin, CJC-1295) that prompt the body's own release.
Compounding is a separate track. A licensed pharmacy may only compound from bulk substances on the FDA's 503A list. BPC-157, TB-500, MOTS-c, KPV, Semax and Epitalon were moved to Category 2 in September 2023, removed from it in April 2026, and recommended for the list by the FDA's advisory committee on 23 and 24 July 2026. No rule has followed as of September 2026, so they still cannot be legally compounded anywhere, including West Virginia. The PCAC vote page has every tally.
GLP-1 compounding is closing, not opening. The FDA has declared the semaglutide and tirzepatide shortages over, proposed in April 2026 to keep both off the 503B bulks list, and sent batches of letters to telehealth sellers in March and June 2026. Vials sold as "GLP-1 S" or "GLP-3 R" for research are unapproved new drugs in the FDA's view wherever the buyer lives.

What West Virginia law adds

West Virginia's controlled-substances law (West Virginia Uniform Controlled Substances Act, W. Va. Code ch. 60A (§ 60A-1-101 et seq.)) decides whether possessing a compound is a state offence. Peptides only become a state-law problem if they appear in those schedules or in a specific state ban. (code.wvlegislature.gov)

Compounds West Virginia has scheduled or restricted

Human growth hormone, Schedule III (W. Va. Code § 60A-2-208(g)) (code.wvlegislature.gov)
Human chorionic gonadotropin (hCG), Schedule III (W. Va. Code § 60A-2-208(i), except approved veterinary use) (code.wvlegislature.gov)

Human growth hormone

West Virginia's own Schedule III lists human growth hormones at § 60A-2-208(g), directly after anabolic steroids, so HGH is a state Schedule III controlled substance, which goes beyond federal law. (W. Va. Code § 60A-2-208(g)) (code.wvlegislature.gov)

Compounded semaglutide and tirzepatide

2023-05-01. The Board of Pharmacy's Statement Concerning Semaglutide Compounding (April 2023, updated 1 May 2023) says compounding semaglutide is generally prohibited as a copy of a commercially available drug and allowed only while the drug is on the FDA shortage list or with a documented patient-specific change; that no salt form of semaglutide (sodium or acetate) may be used because only the base is a component of an approved drug and semaglutide is not on the 503A bulks list; that the active ingredient must be pharmaceutical grade from an FDA-registered establishment; and that research-use-only products may not be used for compounding in any circumstance. (wvbop.com)

This is about licensed pharmacies and prescriptions. It does not make a research vial legal or illegal; those sit under the federal unapproved-drug rules described above.

Clinics, medspas and prescribers

No West Virginia medical board guidance specific to peptide therapy was located. A West Virginia prescriber who administers BPC-157 or another unapproved peptide is exposed under the state's medical practice act and, since the FDA's 2026 letters, under federal law; the July 2026 advisory vote has not changed that yet.

Buying, possessing and using research peptides in West Virginia

Possessing an unscheduled research peptide is not an offence under West Virginia's controlled substances act, but HGH and hCG are state Schedule III substances, and knowing possession of any controlled substance without a valid prescription is a misdemeanor under W. Va. Code § 60A-4-401(c). (code.wvlegislature.gov)

Ordering from a vendor in another state. Almost every research-peptide order into West Virginia is interstate commerce, which is exactly what the FDCA governs. The risk sits with the vendor: the FDA's letters name the seller, and Eli Lilly said in August 2026 it had referred more than 200 sellers to the FDA, the DOJ, state attorneys general and licensing boards. Connecticut's attorney general has already used state consumer-protection law against a "research grade" GLP-1 seller (2025), which is the template other states can copy. The Bureau's vendor scorecard notes which vendors publish batch testing; none of the scored vendors appears in the tracker as of September 2026.

GLP-1 drugs by prescription. Yes, by real-time audio-video or audio-only telemedicine. W. Va. Code § 30-3-13a bars establishing the physician-patient relationship through email, internet questionnaires or text, says a prescription based solely on an online questionnaire is not an acceptable standard of care, and requires an in-person visit with a practitioner within twelve months of the first telemedicine service for the service to continue. (code.wvlegislature.gov) The branded pens are the only fully approved route; compounded versions are now on the wrong side of the FDA's shortage rules.

Sports and employment testing are not a West Virginia law question. Growth hormone secretagogues and GHRH analogues are on the WADA Prohibited List everywhere; a standard workplace panel does not screen for peptides. The national legal guide covers both.

Not sure which of these you actually need?

Answer five questions about your goal, experience and budget and the Stack Builder shows you a matched research protocol on screen, with the compounds, cycle shape and vendor picks from the vendors we score.

Build your stack, 2 minutes

Enforcement in West Virginia

2025-02-19. Attorney General JB McCuskey joined the multistate letter urging the FDA to act against counterfeit GLP-1s and online sellers of research-purposes-only GLP-1 active ingredients. (ago.wv.gov)

A warning letter, lawsuit or board complaint is an allegation by the body that issued it, not a court finding, unless the entry says otherwise.

Editor's note. The Board of Pharmacy site was unreachable directly, so its statement was read from an archived copy. No Board of Medicine statement on peptides or medspas and no disciplinary action tied to GLP-1s or peptides was found.

Frequently asked questions

Is BPC-157 legal in West Virginia?

West Virginia has not scheduled BPC-157, so possessing it is not a West Virginia offence. Federally it is an unapproved new drug: selling it for human use is a violation by the seller, and licensed pharmacies cannot compound it because it is not on the 503A bulks list, despite the advisory committee's July 2026 recommendation. Research vendors sell it under a research-use-only label, which the FDA's 2026 letters treat as no defence when the site shows human use.

Can I get semaglutide or tirzepatide by telehealth in West Virginia?

Yes, by real-time audio-video or audio-only telemedicine. W. Va. Code § 30-3-13a bars establishing the physician-patient relationship through email, internet questionnaires or text, says a prescription based solely on an online questionnaire is not an acceptable standard of care, and requires an in-person visit with a practitioner within twelve months of the first telemedicine service for the service to continue. The West Virginia Board of Pharmacy position on compounded versions: The Board of Pharmacy's Statement Concerning Semaglutide Compounding (April 2023, updated 1 May 2023) says compounding semaglutide is generally prohibited as a copy of a commercially available drug and allowed only while the drug is on the FDA shortage list or with a documented patient-specific change; that no salt form of semaglutide (sodium or acetate) may be used because only the base is a component of an approved drug and semaglutide is not on the 503A bulks list; that the active ingredient must be pharmaceutical grade from an FDA-registered establishment; and that research-use-only products may not be used for compounding in any circumstance.

Is HGH legal in West Virginia?

Only with a valid prescription. West Virginia lists human growth hormone as a controlled substance and federal law, 21 U.S.C. section 333(e), separately makes distribution or possession for a non-approved use a federal offence. Sermorelin, ipamorelin and CJC-1295 are not HGH and fall under the general unapproved-drug rules instead.

Sources

Every West Virginia fact above was checked against the linked source on 28 September 2026. If a statute or board position has changed, email [email protected] with the link and the page will be corrected and dated.